Fleur van der Sijde

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Anti Inflammatory

Gene Expression

Peripheral Blood

Genome Wide Identification

Top Venues

Therapeutic advances in medical oncology

Journal of oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Fleur van der Sijde, Jacob L van Dam, Bas Groot Koerkamp, Brigitte C M Haberkorn, Marjolein Y V Homs, Daniëlle Mathijssen, Marc G H Besselink, Johanna W Wilmink, Casper H J van Eijck
Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study. Journal of oncology 2022 (2022)
Fleur van der Sijde, Zakia Azmani, Marc G Besselink, Bert A Bonsing, Jan Willem B de Groot, Bas Groot Koerkamp, Brigitte C M Haberkorn, Marjolein Y V Homs, Wilfred F J Van IJcken, Quisette P Janssen, Martijn P Lolkema, Saskia A C Luelmo, Leonie J M Mekenkamp, Dana A M Mustafa, Ron H N van Schaik, Johanna W Wilmink, Eveline E Vietsch, Casper H J van Eijck
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX. Therapeutic advances in medical oncology 13 (2021)
Elham Aida Farshadi, Jiang Chang, Bharath Sampadi, Michail Doukas, Freek Van 't Land, Fleur van der Sijde, Eveline E Vietsch, Joris Pothof, Bas Groot Koerkamp, Casper H J van Eijck
Organoids Derived from Neoadjuvant FOLFIRINOX Patients Recapitulate Therapy Resistance in Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)
Fleur van der Sijde, Yunlei Li, Rick Schraauwen, Willem de Koning, Casper H J van Eijck, Dana A M Mustafa
RNA from stabilized whole blood enables more comprehensive immune gene expression profiling compared to RNA from peripheral blood mononuclear cells. PloS one 15 (6) (2020)